CliffBio
small molecule

TRIFERIC

FERRIC PYROPHOSPHATE CITRATE

Loss of exclusivityApril 2029latest FDA-listed patent expiry
CompanyRockwell Medical →See this company's full patent-cliff portfolio

Drug detail

Brand nameTRIFERIC
Active ingredientFERRIC PYROPHOSPHATE CITRATE
Strength272MG IRON/PACKET
Dosage formPOWDER
RouteINTRAVENOUS
ModalitySmall molecule
FDA approvalApril 2016
Marketing statusDISCN

Listed patents

PatentExpiresType
7816404April 2029use U-1656
7857977September 2027use U-1656

More from Rockwell Medical

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.